Latest News and Press Releases

ЛОС-АНДЖЕЛЕС, May 14, 2021 (GLOBE NEWSWIRE) -- Enochian BioSciences, Inc., компания, специализирующаяся на генно-модифицированных клеточных и иммунных методах лечения инфекционных заболеваний и...

LOS ANGELES, May 12, 2021 (GLOBE NEWSWIRE) -- Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced the...

LOS ANGELES, May 12, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today...

LOS ANGELES, March 24, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Seraph Research Institute (SRI) and Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in...

LOS ANGELES, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Enochian BioSciences, a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced that it will...

LOS ANGELES, Sept. 10, 2020 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) − Enochian BioSciences, a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today...

Drs. Carol Brosgart, Peter Revill and Fabien Zoulim will advise on development of a cure for Hepatitis B LOS ANGELES, July 27, 2020 (GLOBE NEWSWIRE) --  (NASDAQ: ENOB) − Enochian BioSciences, a...

Company encouraged by strong alignment with views of FDA’s CBER regarding ENOB-HV-01LOS ANGELES, June 08, 2020 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) - Enochian BioSciences, Inc., a company focused on...

• First presentation of a novel approach to potentially cure HIV  -  An in vivo study demonstrated a 164 percent increase in engraftment of genetically modified cells Poster Presentation -...

Three of three abstracts were accepted for presentation at the Annual Meeting of the American Society of Cell and Gene Therapy (ASCGT);The presentations advance the scientific foundation of Enochian’s...